Clinical trials of Japanese medicine for COVID-19 started in the USA
Hospitals in Massachusetts began the first US clinical trials of a Japanese drug for the treatment of coronavirus, writes Nbc boston.
Three hospitals in Massachusetts have received permission to conduct the first US clinical trial of a Japanese anti-flu drug that can be used to treat coronavirus infection COVID-19.
Trials of the drug, known as the Avigan brand name drug, will take place at the Massachusetts General Hospital, Brigham and Women's Hospital and the UMass Memorial Medical Center.
Doctors participating in the study say that the drug was widely used in treating people and that side effects are relatively well known.
The drug causes viruses to incorrectly “read genetic instructions” and not reproduce properly, which is why the virus eventually “dissolves in vitro,” said Dr. Robert Finberg, an infectious disease specialist at UMass Memorial.
In the United States, between 50 and 60 patients, divided into two groups, will participate in clinical trials. The first group will receive the drug in addition to standard treatment, while the second group will receive only standard therapy.
Japan is currently conducting a similar clinical trial to evaluate the safety of the drug.
The Trump administration is putting pressure on the FDA to approve the drug as a treatment for COVID-19, but there are still concerns about the risks and limited evidence that the drug is effective.
stdClass Object ([term_id] => 12 [name] => In the US [taxonomy] => category [slug] => novosti-ssha)In the U.S.
stdClass Object ([term_id] => 28340 [name] => coronavirus [taxonomy] => post_tag [slug] => koronavirus)coronavirus
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
stdClass Object ([term_id] => 28353 [name] => Coronavirus 2019-nCoV [taxonomy] => special [slug] => kitajskij-koronavirus)
stdClass Object ([term_id] => 28455 [name] => COVID-19 [taxonomy] => post_tag [slug] => covid-19)COVID-19
Read also on ForumDaily:
Let's face the crisis together and support each other
No one in the world expected a coronavirus pandemic, but she came in disrupting the usual rhythm of life and work of billions of people, causing panic and uncertainty about tomorrow.
ForumDaily also faced financial difficulties due to the loss of some advertisers due to the economic downturn and quarantine. But we are not reducing the number of materials and the mode of operation, since we want our readers to receive timely and up-to-date information in this difficult time. In addition, we support Local small businesses in the USA that suffer the most.
But ForumDaily is also a small business. Despite the loss of part of the income, we are doing our best to ensure that you are informed and armed with all the necessary knowledge to counter the pandemic and resolve other important issues during quarantine.
To maintain this rhythm of work, we need your help. We will be grateful for any amount that you are willing to allot to support our team.
Let's face the crisis together!
Security of contributions is guaranteed by the use of the highly secure Stripe system.
Always yours, ForumDaily!
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the option "Priority in the show" - and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.